Oro Eyewear LLC – Trademark Portfolio
Entity Type: 16
Oro Eyewear LLC holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 16 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 5 are pending. Notable registered marks include ORO, BRINX, GRAIL, HUNNIDS, and AUTHENTIC. The owner is based in Los Angeles, CA.
691 Mill Street Unit 806
Los Angeles, CA 90021
Showing of trademarks Trademarks
Trademark Classifications
Oro Eyewear LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Precious metals and their alloys; jewellery, precious stones; horological instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Oro Eyewear LLC have?
Oro Eyewear LLC has 21 U.S. trademarks filed with the USPTO. Of these, 10 registered, 5 pending, 6 abandoned.
What trademark classes does Oro Eyewear LLC file in?
Oro Eyewear LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 14 (Jewelry), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Oro Eyewear LLC's most well-known trademarks?
Oro Eyewear LLC's registered trademark portfolio includes well-known marks such as ORO, BRINX, GRAIL, HUNNIDS, and AUTHENTIC. These are among 10 currently registered trademarks in the portfolio.
What is Oro Eyewear LLC's trademark registration success rate?
Oro Eyewear LLC has a 63% trademark registration rate, with 10 out of 16 resolved applications resulting in successful registration. Currently, 5 applications are pending review.